A detailed history of Susquehanna International Group, LLP transactions in Absci Corp stock. As of the latest transaction made, Susquehanna International Group, LLP holds 35,276 shares of ABSI stock, worth $117,469. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35,276
Previous 104,609 66.28%
Holding current value
$117,469
Previous $322,000 58.39%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.97 - $4.49 $205,919 - $311,305
-69,333 Reduced 66.28%
35,276 $134,000
Q2 2024

Aug 15, 2024

SELL
$2.92 - $6.58 $1.21 Million - $2.72 Million
-413,889 Reduced 79.82%
104,609 $322,000
Q1 2024

May 07, 2024

BUY
$3.41 - $5.74 $629,332 - $1.06 Million
184,555 Added 55.27%
518,498 $2.95 Million
Q4 2023

Feb 14, 2024

BUY
$1.15 - $4.79 $215,202 - $896,367
187,133 Added 127.47%
333,943 $1.4 Million
Q3 2023

Nov 14, 2023

SELL
$1.28 - $2.41 $79,517 - $149,716
-62,123 Reduced 29.73%
146,810 $193,000
Q2 2023

Aug 11, 2023

BUY
$1.17 - $2.03 $77,809 - $135,003
66,504 Added 46.69%
208,933 $317,000
Q1 2023

May 16, 2023

BUY
$1.58 - $3.41 $174,371 - $376,334
110,362 Added 344.16%
142,429 $249,000
Q4 2022

Feb 14, 2023

SELL
$2.0 - $3.58 $4,428 - $7,926
-2,214 Reduced 6.46%
32,067 $67,000
Q3 2022

Nov 14, 2022

SELL
$2.95 - $4.83 $123,448 - $202,121
-41,847 Reduced 54.97%
34,281 $107,000
Q2 2022

Aug 15, 2022

BUY
$3.13 - $8.83 $196,538 - $554,453
62,792 Added 470.85%
76,128 $253,000
Q1 2022

May 16, 2022

BUY
$5.87 - $9.46 $78,282 - $126,158
13,336 New
13,336 $112,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $309M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.